30

R&G PharmaStudies Co LtdSHE 301333 Stock Report

Last reporting period 31 Mar, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.763

Micro

Exchange

XSHE - Shenzhen Stock Exchange

301333.SZ Stock Analysis

30

Uncovered

R&G PharmaStudies Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.763

Dividend yield

0.59 %

Shares outstanding

60 B

R&G PharmaStudies Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 1,876 full-time employees. The company went IPO on 2022-08-02. R&G PharmaStudies Co Ltd is a China-based company mainly engaged in the provision of professional clinical trial outsourcing services. The firm's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The firm operates its businesses primarily in the domestic market.

View Section: Eyestock Rating